Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.

A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Abstract Text:

    xun sunXun Sun,shinichi somadaShinichi Somada,kensuke shibataKensuke Shibata,hiromi mutaHiromi Muta,hisakata yamadaHisakata Yamada,hirofumi yoshiharaHirofumi Yoshihara,kuniomi hondaKuniomi Honda,kazuhiko nakamuraKazuhiko Nakamura,ryhoichi takayanagiRyhoichi Takayanagi,kenzaburo taniKenzaburo Tani,eckhard r podackEckhard R Podack,yasunobu yoshikaiYasunobu Yoshikai,xun sunXun Sun,shinichi somadaShinichi Somada,kensuke shibataKensuke Shibata,hiromi mutaHiromi Muta,hisakata yamadaHisakata Yamada,hirofumi yoshiharaHirofumi Yoshihara,kuniomi hondaKuniomi Honda,kazuhiko nakamuraKazuhiko Nakamura,ryhoichi takayanagiRyhoichi Takayanagi,kenzaburo taniKenzaburo Tani,eckhard r podackEckhard R Podack,yasunobu yoshikaiYasunobu Yoshikai,

    BACKGROUND & AIMS: A CD30-ligand (CD30L) is a 40-kilodalton, type II membrane-associated glycoprotein belonging to the tumor necrosis factor family. Serum levels of soluble CD30 increased in inflammatory bowel diseases (IBD), suggesting that CD30L/CD30 signaling is involved in the pathogenesis of IBD. In this study, we investigated the role of CD30L in oxazolone (OXA)- and trinitrobenzene sulfonic acid (TNBS)-induced colitis in CD30L knockout (KO) mice. METHODS: Colitis was induced by OXA or TNBS in CD30LKO mice with BALB/c or C57BL/6 background, respectively, and diverse clinical signs of the disease were evaluated. Cytokine production from lamina propria T cells of the colon was assessed by enzyme-linked immunosorbent assay. Anti-interleukin (IL)-4 monoclonal antibody (mAb) or agonistic anti-CD30 mAb was inoculated in mice with colitis induced by OXA or TNBS. RESULTS: CD30LKO mice were susceptible to OXA-induced colitis but resistant to TNBS-induced acute colitis. The levels of T helper cell 2 type cytokines such as IL-4 and IL-13 in the LP T cells were significantly higher, but the levels of interferon gamma were lower in OXA- or TNBS-treated CD30LKO mice than in wild-type mice. In vivo administration of agonistic anti-CD30 mAb ameliorated OXA-induced colitis but aggravated TNBS-induced colitis in CD30LKO mice. CONCLUSIONS: These results suggest that CD30L/CD30 signaling is involved in development of both OXA- and TNBS-induced colitis. Modulation of CD30L/CD30 signaling by mAb could be a novel biologic therapy for IBD.

    A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Publishing Authors By Initials

    x sunX Sun,s somadaS Somada,k shibataK Shibata,h mutaH Muta,h yamadaH Yamada,h yoshiharaH Yoshihara,k hondaK Honda,k nakamuraK Nakamura,r takayanagiR Takayanagi,k taniK Tani,er podackER Podack,y yoshikaiY Yoshikai,x sunX Sun,s somadaS Somada,k shibataK Shibata,h mutaH Muta,h yamadaH Yamada,h yoshiharaH Yoshihara,k hondaK Honda,k nakamuraK Nakamura,r takayanagiR Takayanagi,k taniK Tani,er podackER Podack,y yoshikaiY Yoshikai,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Gastroenterology

    VOLUME: 134

    Page Numbers: 447-58

    Journal Abbreviation: Gastroenterology

    ISSN: 1528-0012

    DAY: 4

    MONTH: 11

    YEAR: 2007

    A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 374630

    A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.

    AFFILIATION: Division of Host Defense, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Gastroenterology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News